HSDT
Solana Company Class A Common Stock (DE)
stockNASDAQ
helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.02 | 2026-11-02 | -5.21% | 1.767 |
| 1M | 2.39 | 2026-10-09 | -20.08% | 2.312 |
| 3M | 1.70 | 2026-08-10 | +12.35% | 3.346 |
| 6M | 2.22 | 2026-05-08 | -13.96% | 2.731 |
| 1Y | 5.38 | 2025-11-10 | -64.50% | 2.886 |
| 2Y | 426.00 | 2024-11-08 | -99.55% | — |
| 5Y | 453,937.50 | 2021-11-09 | -100.00% | 1.417 |
Solana Company Class A Common Stock (DE) (NASDAQ:HSDT) stock price today is $1.91, and today's volume is 529,516. HSDT is down 1.036% today. The 30 day average volume is 538,741. HSDT market cap is $124.35M with 65.10M shares outstanding.